Role of Class IIa HDACs HDAC4 and HDAC7 in Pathogenic Th17 Cell Development and Colitis
IIa 类 HDAC HDAC4 和 HDAC7 在致病性 Th17 细胞发育和结肠炎中的作用
基本信息
- 批准号:10557888
- 负责人:
- 金额:$ 42.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:Autoimmune DiseasesBacterial InfectionsBindingC-terminalCD4 Positive T LymphocytesCell Differentiation processCell LineageCell MaintenanceCellsChIP-seqChemicalsChromatinColitisColonColonic inflammationCommunitiesComplexDataDevelopmentDiseaseEnzymesGenesGenetic TranscriptionHDAC4 geneHDAC7 histone deacetylaseHealthHelper-Inducer T-LymphocyteHistone DeacetylaseHistone Deacetylase InhibitorHumanIL10 geneIL17 geneInflammationInflammatoryInflammatory Bowel DiseasesInterleukin-6Lamina PropriaMalignant NeoplasmsMapsMediatingModelingMolecularMucous MembraneMultiple SclerosisMusMycosesN-terminalNucleic Acid Regulatory SequencesOutcomePathogenicityPatientsPhysiologicalPlayProteinsRegulationRegulator GenesRegulatory ElementRegulatory T-LymphocyteRepressionResearchRheumatoid ArthritisRoleSignal PathwayT-Cell DevelopmentT-LymphocyteTherapeuticTranscriptional Regulationadaptive immunitycell typecytokineeffective therapyempowermentgene repressiongenetic approachgut inflammationinhibitorinterleukin-23mesenteric lymph nodemigrationmurine colitisnovelnovel therapeutic interventionpharmacologicprogramsrecruitsingle-cell RNA sequencingtranscription factortranscriptome sequencingtranslational potentialvirulence gene
项目摘要
PROJECT SUMMARY
Th17 cells play important roles in adaptive immunity and autoimmune diseases. In normal physiological
conditions, Th17 cells produce IL-17A and IL-17F to protect the mucosa from bacterial and fungal infections.
Dysregulation of Th17 cells, however, is responsible for inflammatory bowel diseases, multiple sclerosis and
rheumatoid arthritis. Differentiation of Th17 cell lineage has been investigated intensively and has yielded
significant results. The cooperation of key transcriptional factors such as Irf4, Batf, Stat3 together with lineage-
specific regulator RorgT defines the transcriptional program and function of Th17 cells. These regulatory
networks are induced by IL-6 and TGF-b1, and further IL-23 signaling pathways promote the development of
pathogenic Th17 cells. To identify Th17-specific regulators, we recently conducted comprehensive ChIP-seq
and RNA-seq studies of Th17 cells and discovered Class IIa Hdacs Hdac4 and Hdac7 as candidates that are
transcriptionally regulated by Stat3 and BET proteins. We further found that Hdac4 and Hdac7 co-localize with
distinct transcription factors JunB and Bhlhe40 on cis-regulatory regions of genes, to activate Th17 pathogenic
genes (Il23r, Tgfb3, Il22, Csf2) and repress regulatory gene (Il10), respectively, during pathogenic Th17 cell
differentiation (IL-6+IL-23+IL-1b). However, we still have limited mechanistic understanding how Hdac4 and
Hdac7 function distinctly in pathogenic Th17 cell development. It is also unclear how Hdac4 and Hdac7
facilitate Th17 pathogenicity through the regulation of Th17 cell maintenance and/or plasticity in colitis. We
therefore aim to delineate the role of Hdac4 and Hdac7 in Th17 cell-mediated inflammation, and establish the
feasibility of pharmacological inhibition of Hdac4 and/or Hdac7 as a novel therapeutic strategy to treat Th17-
related colitis.
项目总结
Th17细胞在获得性免疫和自身免疫性疾病中发挥重要作用。在正常生理状态下
在这种情况下,Th17细胞产生IL-17A和IL-17F,以保护粘膜免受细菌和真菌的感染。
然而,Th17细胞的失调是炎症性肠病、多发性硬化症和
类风湿关节炎。Th17细胞系的分化已被深入研究并取得了成果
取得了重大成果。IRF4、BATF、STAT3等关键转录因子与谱系的协同作用--
特异性调节因子RorgT定义Th17细胞的转录程序和功能。这些监管规定
IL-6和转化生长因子-β1诱导的网络,进一步的IL-23信号通路促进肿瘤的发展。
致病Th17细胞。为了识别Th17特定的调节器,我们最近进行了全面的芯片序列
和对Th17细胞的RNA-SEQ研究,发现IIa类HDAC4和HDAC7是候选的
受STAT3和BET蛋白转录调控。我们进一步发现,HDAC4和HDAC7与
不同转录因子JunB和Bhlhe40位于基因顺式调控区,激活Th17致病因子
致病Th17细胞中的抑制基因(Il23r、TGFB3、Il22、CSF2)和抑制基因(Il10
分化(IL-6+IL-23+IL-1b)。然而,我们对HDAC4和HDAC4的机械理解仍然有限
HDAC7在致病Th17细胞的发育过程中发挥着重要作用。目前也不清楚HDAC4和HDAC7如何
通过调节结肠炎中Th17细胞的维持和/或可塑性来促进Th17的致病作用。我们
目的阐明HDAC4和HDAC7在Th17细胞介导的炎症反应中的作用,并建立
药物抑制HDAC4和/或HDAC7作为治疗Th17的新策略的可行性
相关性结肠炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kalung Cheung其他文献
Kalung Cheung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kalung Cheung', 18)}}的其他基金
Mechanism of Transcriptional Regulation of Th2 Cell Development
Th2细胞发育的转录调控机制
- 批准号:
10716014 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Role of Class IIa HDACs HDAC4 and HDAC7 in Pathogenic Th17 Cell Development and Colitis
IIa 类 HDAC HDAC4 和 HDAC7 在致病性 Th17 细胞发育和结肠炎中的作用
- 批准号:
10711935 - 财政年份:2022
- 资助金额:
$ 42.25万 - 项目类别:
Role of Class IIa HDACs HDAC4 and HDAC7 in Pathogenic Th17 Cell Development and Colitis
IIa 类 HDAC HDAC4 和 HDAC7 在致病性 Th17 细胞发育和结肠炎中的作用
- 批准号:
10417716 - 财政年份:2022
- 资助金额:
$ 42.25万 - 项目类别:
相似海外基金
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
- 批准号:
10574286 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
- 批准号:
MR/X031993/1 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
- 批准号:
EP/X014479/1 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
- 批准号:
10073241 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:














{{item.name}}会员




